# Testosterone for Peripheral Vascular Disease

> **NCT00504712** · PHASE4 · COMPLETED · sponsor: **Barnsley Hospital** · enrollment: 24 (actual)

## Conditions studied

- Hypogonadism
- Peripheral Vascular Disease
- Type 2 Diabetes

## Interventions

- **DRUG:** Testosterone
- **DRUG:** saline

## Key facts

- **NCT ID:** NCT00504712
- **Lead sponsor:** Barnsley Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00504712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00504712, "Testosterone for Peripheral Vascular Disease". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00504712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*